Seeds

 

TheraSeed® Palladium 103, Model 200


 

• Industry Benchmark
• Unrivaled, long-term clinical experience
• Exclusive design; distinctive concave end cups
• 16.9 day half life; 20-23 keV principle energy
• Widest range of available activities


AgX100® – Iodine 125, Model AgX100


• Designed after the recognized I-125 seed industry benchmark with long-term clinical experience
• Longer, more stable silver core for improved image clarity
• 59.4 day half life; 27-35 keV principle energy
• Widest range of available activities


Download PDF: Theragenics Brachytherapy Product Portfolio


Dosimetric characterization of TheraSeed and AgX100 include Monte Carlo and experimental studies conducted in accordance with the AAPM Task Group 43 update (TG43U1). For references, please visit the AAPM Sealed Source Device Registry: http://rpc.mdanderson.org/RPC/home.htm

TheraSeed: http://rpc.mdanderson.org/rpc/BrachySeeds/TheraSeed_model_200.htm
AgX100: http://rpc.mdanderson.org/rpc/BrachySeeds/AgX100.htm

 

1Rivard, et al., “Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations”, Med Phys. 31, 663-674, (2004)